Acurx Pharmaceuticals annual current ratio
2021
2022
2023
2024
2025
Acurx Pharmaceuticals Current Ratio Growth & History (ACXP)
Acurx Pharmaceuticals's current ratio was 3.18 for fiscal 2025.
View full Acurx Pharmaceuticals company overviewAcurx Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 3.18 | 1.99 | +166.98% |
| 2024 | 2024-12-31 | 1.19 | −1.34 | −53.05% |
| 2023 | 2023-12-31 | 2.53 | −2.01 | −44.29% |
| 2022 | 2022-12-31 | 4.55 | −11.16 | −71.04% |
| 2021 | 2021-12-31 | 15.71 | — | — |
Acurx Pharmaceuticals quarterly current ratio
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.88 | 1.50 | +63.20% |
| Q1 2026 | 2026-03-31 | 3.78 | 1.85 | +95.95% |
| Q4 2025 | 2025-12-31 | 3.18 | 1.99 | +166.98% |
| Q3 2025 | 2025-09-30 | 2.47 | 0.67 | +37.21% |
| Q2 2025 | 2025-06-30 | 2.38 | — | — |
| Q1 2025 | 2025-03-31 | 1.93 | — | — |
| Q4 2024 | 2024-12-31 | 1.19 | −1.34 | −53.05% |
| Q3 2024 | 2024-09-30 | 1.80 | −0.42 | −18.82% |
| Q4 2023 | 2023-12-31 | 2.53 | −2.01 | −44.29% |
| Q3 2023 | 2023-09-30 | 2.22 | −7.04 | −76.02% |
| Q2 2023 | 2023-06-30 | 3.06 | −16.37 | −84.26% |
| Q1 2023 | 2023-03-31 | 3.56 | — | — |
| Q4 2022 | 2022-12-31 | 4.55 | −11.16 | −71.04% |
| Q3 2022 | 2022-09-30 | 9.26 | — | — |
| Q2 2022 | 2022-06-30 | 19.43 | — | — |
| Q4 2021 | 2021-12-31 | 15.71 | — | — |
Acurx Pharmaceuticals current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Acurx Pharmaceuticals's current ratio decreased from 15.71 to 3.18, a change of −12.53. The latest reported quarter, Q2 2026, shows 3.88.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acurx Pharmaceuticals source filings ↗